Los Angeles Capital Management LLC Foghorn Therapeutics Inc. Transaction History

Los Angeles Capital Management LLC

  • $28.5 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025
BUY
$3.15 - $4.9 $35,358 - $55,002
11,225 Added 70.71%
27,099 $127,000
Q1 2025

May 05, 2025
BUY
$3.52 - $6.16 $80 - $141
23 Added 0.15%
15,874 $57,000
Q4 2024

Feb 04, 2025
BUY
$4.61 - $9.35 $73,073 - $148,206
15,851 New
15,851 $74,000

Others Institutions Holding FHTX

# of Institutions
88
Shares Held
37M
Call Options Held
100
Put Options Held
0
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $195M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email